The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a major legal development removing a key overhang for major German corporates, Bayer (BAYRY) announced it won a US Supreme Court case over its Roundup herbicide. The court overturned a previous jury award to a Missouri man who claimed the product causes cancer, saving the company billions of dollars, according to reports. Bayer shares surged on Thursday June 25, pushing the DAX index toward a critical level.
BAYRY closed at $13.16 on June 25, up from an intraday low of $11.27, per market data. Rheinmetall (RNMBY) ended at $214.05 while Volkswagen (VWAGY) settled at $8.87. The victory strengthens Bayer's legal position against thousands of similar lawsuits, potentially capping future damages.
Sign in to access this content
Sign InLooking ahead, investors will watch for broader market reactions and implications for the chemicals sector. Markets also await a speech by ECB President Christine Lagarde later today and past comments from Fed's Christopher Waller, which may steer European indices and currencies. BAYRY at $13.16 (June 25 close) may test resistance at $13.40 if positive momentum continues.